Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Tuesday, August 16, 2022

Lucintel Forecasts Middle Eastern and North African Active Pharmaceutical Ingredient (API) Market to Reach $5.4 Billion by 2027

According to the recent study the Middle Eastern and North African active pharmaceutical ingredient (API) market is projected to reach an estimated $5.4 billion by 2027 from $3.4 billion in 2021, at a CAGR of 7.9% from 2021 to 2027. Growth in this market is primarily driven by pharmaceutical production and research and development of new drugs.

Browse 97 figures / charts and 71 tables in this 158 -page report to understand trends, opportunities and forecast in Middle Eastern and North African active pharmaceutical ingredient (API) market by synthesis type (synthetic chemical, biotech and biologics, plant extracts, fermentation, and others), manufacturer type (captive API and merchant API), therapeutic area (cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, aliment, anti-inflammatory, and others ), product form (liquid API and powder API), molecule type (large molecule and small molecule), and drug type (branded, generic, and over-the-counter).

Download sample report by clicking on https://www.lucintel.com/middle-eastern-and-north-african-active-pharmaceutical-ingredient-market.aspx.

“Synthetic chemical market is expected to remain the largest segment during the forecast period.”

Based on synthesis type, the Middle Eastern and North African active pharmaceutical ingredient (API) market is segmented into synthetic chemical, biotech and biologics, plant extracts, fermentation, and others. Lucintel forecasts that the synthetic chemical market is expected to remain the largest segment due to continuous research and development activities and growing demand of synthetic chemical APIs in therapeutic areas.

“Within the Middle Eastern and North African active pharmaceutical ingredient (API) market, the cardiology segment is expected to remain the largest therapeutic area.”

Based on therapeutic area the cardiology segment is expected to witness the highest growth over the forecast period due to increasing cardiovascular diseases and increase in geriatric population.

Download Brochure of this report by clicking on https://www.lucintel.com/middle-eastern-and-north-african-active-pharmaceutical-ingredient-market.aspx.

Major players of Middle Eastern and North African active pharmaceutical ingredient (API) market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Pfizer, Teva Pharmaceutical, GSK, Sun Pharmaceutical, Novartis, Aurobindo, Merck& Co., BASF, Julphar, and AbbVie are among the major Middle Eastern and North African active pharmaceutical ingredient (API) providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/middle-eastern-and-north-african-active-pharmaceutical-ingredient-market.aspx or helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email:
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Mhealth Solution Market:

For more details click here https://www.lucintel.com/mhealth-solution-market.aspx

 

Minimally Invasive Surgery Market:

For more details click here https://www.lucintel.com/minimally-invasive-surgery-market.aspx

 

Medical Aesthetic Market:

For more details click here https://www.lucintel.com/medical-aesthetic-market.aspx

 

Neurostimulation Market:

For more details click here https://www.lucintel.com/neurostimulation-market.aspx

 

Nuclear Medicine/Radiopharmaceutical Market:

For more details click here https://www.lucintel.com/nuclear-medicine-radiopharmaceutical-market.aspx

 

Liquid Biopsy Market:

For more details click here https://www.lucintel.com/liquid-biopsy-market.aspx

 

Digital Fitness Market:

For more details click here https://www.lucintel.com/digital-fitness-market.aspx

 

Digital X-Ray Market:

For more details click here https://www.lucintel.com/digital-xray-market.aspx

 

Medical Robot Market:

For more details click here https://www.lucintel.com/medical-robot-market.aspx

 

Healthcare IT Market:

For more details click here https://www.lucintel.com/healthcare-it-market.aspx

No comments:

Post a Comment